报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 4.44% | 5.46% | 60.87% | 20/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
2024-06-30 | 2.76% | -13.21% | 93.01% | 16/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
2024-03-31 | 1.43% | -28.86% | -69.89% | 17/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
2023-12-31 | 4.75% | 5.79% | 12.83% | 24/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
2023-09-30 | 4.21% | 2% | 32.39% | 28/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
2023-06-30 | 3.18% | 21.84% | 58.21% | 25/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
2023-03-31 | 2.01% | 2% | -55.23% | 21/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
2022-12-31 | 4.49% | -34.16% | 72.03% | 30/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
2022-06-30 | 2.61% | -39.86% | -61.73% | 30/51 | 5.56% | 博腾股份 | 39.77% | 行业排名> |
2021-12-31 | 6.82% | -5.8% | 57.14% | 33/51 | -6.68% | 睿智医药 | 41.16% | 行业排名> |
2021-06-30 | 4.34% | 17.93% | -40.06% | 29/51 | 2.28% | 澳洋健康 | 51.68% | 行业排名> |
2020-12-31 | 7.24% | -41.75% | 96.74% | 34/51 | 10.95% | 澳洋健康 | 40.93% | 行业排名> |
2020-06-30 | 3.68% | 2% | -70.39% | 22/51 | 2.48% | 金域医学 | 43.58% | 行业排名> |
2019-12-31 | 12.43% | 3.67% | 3.67% | 23/51 | 65.31% | 金域医学 | 35.41% | 行业排名> |
2018-12-31 | 11.99% | -24.5% | -24.5% | 21/51 | -0.6% | 阳光诺和 | 26.2% | 行业排名> |
2017-12-31 | 15.88% | 2% | 2% | 10/51 | 1.73% | 金域医学 | 13.23% | 行业排名> |